Roselabs Finance Limited (BOM:531324)
India · Delayed Price · Currency is INR 20.80
0.00 (0.00%)
At close: Oct 23, 2026
Roselabs Finance Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.17 | 0.53 | 1.16 | 0.68 | 0.04 | 0.28 |
Cash & Short-Term Investments | 0.17 | 0.53 | 1.16 | 0.68 | 0.04 | 0.28 |
Cash Growth | 334.21% | -54.52% | 70.48% | 1692.11% | -86.28% | -46.00% |
Accounts Receivable | - | - | - | 13.4 | - | - |
Receivables | - | - | - | 13.4 | - | - |
Other Current Assets | 0.18 | 0.05 | 0.01 | - | - | - |
Total Current Assets | 0.35 | 0.58 | 1.17 | 14.08 | 0.04 | 0.28 |
Long-Term Deferred Tax Assets | - | - | 1.09 | 1.09 | 1.09 | 1.09 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | - | 0.47 |
Total Assets | 0.35 | 0.59 | 2.27 | 15.18 | 1.13 | 1.84 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.17 | 0.16 | 0.16 | 13.83 | 0.88 | 0.82 |
Accrued Expenses | - | 0.03 | 0.04 | 0.06 | 0.03 | 0.1 |
Short-Term Debt | 51.55 | - | - | - | - | - |
Other Current Liabilities | 0.14 | - | - | - | - | 14.86 |
Total Current Liabilities | 51.85 | 0.19 | 0.21 | 13.89 | 0.91 | 15.78 |
Long-Term Debt | - | 50.75 | 49.34 | 45.66 | 43.26 | 49.26 |
Total Liabilities | 51.85 | 50.93 | 49.54 | 59.54 | 44.17 | 65.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 100 | 100 | 100 | 100 | 100 | 100 |
Retained Earnings | -151.5 | -150.35 | -147.28 | -144.36 | -143.04 | -163.2 |
Shareholders' Equity | -51.5 | -50.35 | -47.28 | -44.36 | -43.04 | -63.2 |
Total Liabilities & Equity | 0.35 | 0.59 | 2.27 | 15.18 | 1.13 | 1.84 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 51.55 | 50.75 | 49.34 | 45.66 | 43.26 | 49.26 |
Net Cash (Debt) | -51.38 | -50.22 | -48.17 | -44.97 | -43.22 | -48.98 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -5.16 | -5.02 | -4.82 | -4.50 | -4.32 | -4.90 |
Filing Date Shares Outstanding | 10.07 | 10 | 10 | 10 | 10 | 10 |
Total Common Shares Outstanding | 10.07 | 10 | 10 | 10 | 10 | 10 |
Working Capital | -51.5 | 0.39 | 0.96 | 0.19 | -0.88 | -15.5 |
Book Value Per Share | -5.12 | -5.03 | -4.73 | -4.44 | -4.30 | -6.32 |
Tangible Book Value | -51.5 | -50.35 | -47.28 | -44.36 | -43.04 | -63.2 |
Tangible Book Value Per Share | -5.12 | -5.03 | -4.73 | -4.44 | -4.30 | -6.32 |